Benzinga | Jul 28, 2021 06:57AM EDT

Myovant Sciences Q1 EPS $(0.67) Misses $(0.33) Estimate, Sales $41.10M Miss $57.05M Estimate

Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.33) by 103.03 percent. This is a 81.08 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $41.10 million which missed the analyst consensus estimate of $57.05 million by 27.96 percent. This is a 23.30 percent increase over sales of $33.33 million the same period last year.